Cairn Biosciences

Cairn Biosciences is a drug discovery company that leverages a proprietary live-cell imaging and analysis platform to develop next-generation therapeutics. By monitoring cellular dynamics in real-time, the company identifies novel drug candidates that modulate complex biological pathways, with a primary focus on oncology and neurodegeneration. Their approach combines advanced microscopy, machine learning, and cell biology to overcome the limitations of traditional endpoint assays. Cairn aims to discover small molecules that address unmet medical needs through a deeper understanding of dynamic cellular responses. The company's platform is particularly effective at identifying compounds that target transcriptional regulation and cell cycle control.